Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Genmab
Genmab
Incyte Corporation
Acerta Pharma BV
Fred Hutchinson Cancer Center
Hoffmann-La Roche
Ohio State University Comprehensive Cancer Center
Regeneron Pharmaceuticals
Mayo Clinic
University of Wisconsin, Madison
Massachusetts General Hospital
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
Sana Biotechnology
City of Hope Medical Center
Sana Biotechnology
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
University of Rochester
University Hospital Southampton NHS Foundation Trust
City of Hope Medical Center
University of Chicago
City of Hope Medical Center
Synthekine
Shanghai Ming Ju Biotechnology Co., Ltd.
Genmab
Malaghan Institute of Medical Research
Peter MacCallum Cancer Centre, Australia